康希诺生物将注销40.61万股A股回购股份

Core Viewpoint - 康希诺生物 announced the cancellation of 406,100 shares from its repurchase account due to non-compliance with the intended use for employee stock ownership or equity incentives within the stipulated three-year period [1] Group 1: Regulatory Compliance - The company is adhering to the regulations set forth by the Company Law of the People's Republic of China and the relevant rules for share repurchase [1] - According to the guidelines, shares repurchased for employee stock ownership or equity incentives must be transferred within three years of repurchase [1] Group 2: Share Cancellation - 康希诺生物 will cancel all 406,100 shares that were not utilized for the intended purposes, leading to a corresponding reduction in the company's registered capital [1]